BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Orexo Announces Conditional Total Redemption of its Senior Unsecured Bonds

  Orexo announces today that the Company will issue a notice of conditional early total redemption of its outstanding SEK 342,000,000 senior unsecured callable floating rate bonds due 2018 with ISIN SE0005932159 in accordance with the terms and conditions of the Bonds.

  October 27, 2017

   · 

  3 min read
• Business

  Hoya Reports Second Quarter Results; Record Half Year Results

  Hoya Corporation today announced financial results for the second quarter ended September 30, 2017.

  October 27, 2017

   · 

  2 min read
• Biotech Beach

  Ionis Pharma Announces Plans to Open Expanded Access Program to Provide Inotersen to Patients With Hereditary TTR Amyloidosis in the U.S.

  Ionis Pharma announced today that it plans to open an expanded access program for eligible patients with hereditary transthyretin amyloidosis with polyneuropathy in the coming months.

  October 27, 2017

   · 

  6 min read
• Business

  MR Solutions Restructures for Ongoing Expansion

  MR Solutions is expanding its management team following world-wide sales success of their ground-breaking, cryogen free preclinical MRI scanners.

  October 27, 2017

   · 

  2 min read
• Policy

  Eagle Pharmaceuticals Receives Tentative FDA Approval for PEMFEXY (Pemetrexed Injection) Ready-to-Dilute

  Eagle submitted, and the FDA accepted for filing, its NDA under Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act for PEMFEXY ready-to-dilute in December 2016.

  October 27, 2017

   · 

  4 min read
• Karolinska Development - Interim Report (January-September 2017) - Invitation To Conference Call And Webcast

  The company will also host a conference call and an online presentation on October 31, at 2 pm CET.

  October 27, 2017

   · 

  1 min read
• Pharm Country

  CRF Health’s TrialMax Touch Solution Selected for Landmark Global Oncology Study

  The three year study marks CRF Health’s involvement in over 115 oncology studies which have realized the benefits of electronically collected eCOA data, and aims to better understand patients’ quality of life post-treatment.

  October 27, 2017

   · 

  2 min read
• UBM Release: New Dedicated Biopharma Event Launches Alongside CPhI Worldwide 2018 in Madrid

  The new event has been created after independent research identified a gap in the market for a new global exhibition and content platform that could establish premium-class, global leadership across the entire bio manufacturing value chain.

  October 27, 2017

   · 

  5 min read
• Ablynx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and End of Stabilization Period

  The exercise of the greenshoe option also marks the end of the stabilization period in relation to the initial U.S. public offering.

  October 27, 2017

   · 

  5 min read
• Business

  Cara Therapeutics to Announce Third Quarter 2017 Financial Results on November 2, 2017

  An archived webcast recording will be available on the Cara website beginning approximately two hours after the call.

  October 27, 2017

   · 

  1 min read